<article id="weyckler_2006" class="slide" data-ag-slide-name="Weyckler 2006">
    <div class="basic">
      <h1 data-ag-editable="Weycker 2006 Main Title">How many days of G-CSF are needed?</h1>
      <div id="fn_page2_top">
         <p class="red_subtitle" data-ag-editable="Weycker 2006 Copy Top">Risk of hospitalisation vs days of daily G-CSF prophylaxis<sup>1</sup></p>
      </div>
      <div id="weyckler_2006_graph_holder">
         <div id="weyckler_2006_large" class="main_content_style">
            <img src="content/images/carer_pages/burden_of_fn/weycker_2006_large.png" width="788" height="564" data-ag-editable="Weycker 2006 Graph Background" />
            <div id="weyckler_2006_graph_vertical_numbers">
               <ul data-ag-editable="Weycker 2006 Graph Vertical Axis Data">
                  <li>40%</li>
                  <li>35%</li>
                  <li>30%</li>
                  <li>25%</li>
                  <li>20%</li>
                  <li>15%</li>
                  <li>10%</li>
                  <li>5%</li>
                  <li>0%</li>
               </ul>
            </div>
            <div id="weyckler_2006_graph_horizontal_numbers">
               <ul data-ag-editable="Weycker 2006 Graph Horizontal Axis Data">
                  <li>1</li>
                  <li>2</li>
                  <li>3</li>
                  <li>4</li>
                  <li>5</li>
                  <li>6</li>
                  <li>7</li>
                  <li>8</li>
                  <li>9</li>
                  <li>10</li>
                  <li>11</li>
                  <li>12</li>
                  <li>13</li>
                  <li>14</li>
               </ul>
            </div>
            <div id="weyckler_2006_graph_content_large">
                <p id="graph1_vertical_axis_title_large" data-ag-editable="Weyckler 2006 Vertical Axis Title">Risk of hospitalisation</p>
                <p id="graph1_horizontal_axis_title_large" data-ag-editable="Weyckler 2006 Horizontal Axis Title">Days of filgrastim prophylaxis</p>
                <p id="graph1_legend_1_large" data-ag-editable="Weyckler 2006 Graph Legend 1">Breast Cancer</p>
                <p id="graph1_legend_2_large" data-ag-editable="Weyckler 2006 Graph Legend 2">Non-Hodgkin's Lymphoma</p>
                <p id="graph1_legend_3_large" data-ag-editable="Weyckler 2006 Graph Legend 3">Lung Cancer</p>
                <p id="graph1_bottom_text_large" data-ag-editable="Weyckler 2006 Bottom Text">Adapted from Weycker, D. <em>et al.</em> 2006<sup>1</sup>
Predicted risk of hospitalisation for neutropenia or infection. Based on coefficients from generalised estimating model and assuming mean Charlson Co morbidity Index, cycle 1, and no recent history of hospitalisation or anaemia</p>
            </div>
         </div>
      </div>
      <div id="fn_page2_bottom">
         <ul data-ag-editable="Weycker 2006 List Bottom">
            <li><p>Frequent monitoring of ANC per cycle is required for acurate dosing with daily G-CSF<sup>1,2</sup></p></li>
         </ul>
      </div>
    </div>
    <div class="enlarge_graph" id="enlarge_graph_weykcler_2006"></div>
    <!-- Reference Information Starts -->
    <div class="lightbox_data" id="weyckler_2006_refs">
       <div class="main_content_style">
          <p><strong data-ag-editable="Weycker 2006 References Title">References:</strong></p>
          <br />
          <div data-ag-editable="Weycker 2006 References List">
             <ol>
                <li>Weycker D <em>et al</em>. Are Shorter Courses of Filgrastim Prophylaxis Associated with Increased Risk
   of Hospitalisation? Ann Phamaco 2006; 40(3):402-407</li>
                <li>Neupogen<sup>®</sup>, Summary of Product Characteristics, March 2011</li>
             </ol>
          </div>
          <p data-ag-editable="Weycker 2006 References Bottom Copy">The recommended dose of filgrastim (NEUPOGEN<sup>®</sup>) is 0.5 MU (5 μg/kg/day)<sup>2</sup></p>
       </div>
    </div>
    <!-- Reference Information Ends -->
</article>